CTIS2023-506088-33-00进行中(未招募)1 期
Allogenic mesenchymal stem cell intraarticular injection for knee osteoarthritis therapy, an RCT explorative mode-of-action study
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+(—)
- 性别
- All
入选标准
- •Donor, 1. Male or female aged 40 to <75 years, 2. Chronic knee pain (defined for at least 6 months with NRS 4 or above when pain worst), 3. Patients with Grade II-III osteoarthritis according to the Kellgren Lawrence Classification and a joint width space of 1-3 mm., 4. Axial hip, knee, ankle x-ray with no more than 5 degrees valgus/varus deformity, 5. Medial, lateral or dual compartment OA as determined above, 6. BMI <35, 7. Danish speaker, 8. Patients must be legally competent and must be able to sign the written consent, 1. Male or female aged 18-50 years, 2. Planned cosmetic operation of excessive fat of abdominal, flank, arm and thigh fat, 3. BMI 18,5-30, 4. Non-smokers (defined as smoking cessation >12 weeks), 5. Operation of at least 30 mL adipose tissue, 6. Speaks Danish, 7. Legally competent and able to sign the written consent, Patient
排除标准
- •Donor, 1. Severe Osteoarthritis (Grade IV according to Kellgren Lavrence Classification), 2. Intraarticular tumor, infection or fracture, 3. Pregnancy and breast feeding, 4. Cognitive impairment, 5. Treatment with cytostatic drugs, 6. Previous intraarticular knee injection in the past 3 mo., 7. Unable to perform MRI scan (non-compatible implants, claustrophobia and severe obesity (>BMI 35), 8. Previous ligament reconstruction, 9. Meniscal operation with resection with more than 50% or multiple meniscal operations (more than one resection), 10. Knee instability on physical examination, 1. Age >50 years, 11. History of allergy to antibiotics, 12. Diabetes mellitus type 1 or dysregulated type 2 diabetes, 13. Concomitant severe infection, malignant tumor, coagulation diseases, autoimmune disease or uncontrolled or unmanaged systemic disease, 14. Presence of other types of inflammatory arthritis, 2. BMI >30 or <18,4, 3. Known comorbidities: diabetes mellitus Type I and II, infectious diseases (HIV, hepatitis B, hepatitis C or syphilis), cancer, autoimmune disorders, metabolic diseases (hyper and hypothyreosis), metabolic syndrome, 4. Taking immunosuppressive/immunomodulating medication, 5. Breastfeeding, 6. Cognitive impairment, 7. Active smoker, Patient
研究者
相似试验
招募中
1 期
Allogenic mesenchymal stem cell intraarticular injection for knee osteoarthritis therapy, an RCT explorative mode-of-action studyMedDRA version: 21.1Level: LLTClassification code: 10023476Term: Knee osteoarthritis Class: 10028395knee osteoarthritisCTIS2023-506088-33-01Aarhus University80
尚未招募
1 期
Transplantation of stem cells for the treatment of type 1 diabetes.Type 1 diabetes mellitus (T1DM).Type 1 diabetes mellitusIRCT20210925052566N1Endocrinology and Metabolism Research Institute30
撤回
不适用
Intra-arterial autologous myogenic stem cell therapy for m.3243A>G mutation carriersmitochondrial myopathymitochondrial muscular disease10028302NL-OMON42959Erasmus MC, Universitair Medisch Centrum Rotterdam5
已完成
1 期
Autologous Bone Marrow Mesenchymal Stem Cells Transplantation for Articular Cartilage Defects RepairOsteoarthritisNCT01895413Alexandra Cristina Senegaglia10
进行中(未招募)
1 期
Clinical study on mesenchymal Cell Therapy for SARS-CoV-2 PneumoniaSARS-CoV-2 pneumoniaMedDRA version: 22.1Level: LLTClassification code 10061229Term: Lung infectionSystem Organ Class: 100000004862EUCTR2020-001577-70-ITAZIENDA OSPEDALIERO-UNIVERSITARIA DI MODENA60
